Targeted therapy in esophageal cancer

作者: Md Sazzad Hassan , Victoria Makuru , Urs von Holzen

DOI: 10.1586/17474124.2016.1140036

关键词: Esophageal cancerTyrosine kinaseMonoclonal antibodyClinical trialRadiation therapyInternal medicineTargeted therapyC-MetOncologyChemotherapyMedicine

摘要: … for the treatment of many different cancer types, including esophageal cancer. Herein, we … trials in esophageal cancer targeted therapies, and discuss the different targeted pathways. …

参考文章(87)
Johanna C. Bendell, Anthony Meluch, Mark Rubin, John D. Hainsworth, Howard A. Burris, James Peyton, David Waterhouse, Charles Webb, A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancer. Clinical advances in hematology & oncology. ,vol. 10, pp. 430- 437 ,(2012)
Xizhi Zhang, Jia Chen, Min Tao, Xiaoyuan Chu, Yang Ling, A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma. Journal of Thoracic Disease. ,vol. 4, pp. 58- 62 ,(2012) , 10.3978/J.ISSN.2072-1439.2011.08.02
C Wu, S Mikhail, L Wei, C Timmers, S Tahiri, A Neal, J Walker, S El-Dika, M Blazer, J Rock, D J Clark, X Yang, J L Chen, J Liu, M V Knopp, T Bekaii-Saab, A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers British Journal of Cancer. ,vol. 113, pp. 220- 225 ,(2015) , 10.1038/BJC.2015.197
Dongxian Jiang, Xiaojing Li, Haixing Wang, Yuan Shi, Chen Xu, Shaohua Lu, Jie Huang, Yifan Xu, Haiying Zeng, Jieakesu Su, Yingyong Hou, Lijie Tan, The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma BMC Cancer. ,vol. 15, pp. 377- 377 ,(2015) , 10.1186/S12885-015-1393-8
D. P. S. Sohal, T. W. Rice, L. A. Rybicki, C. P. Rodriguez, G. M. M. Videtic, J. P. Saxton, S. C. Murthy, D. P. Mason, B. E. Phillips, R. R. Tubbs, T. Plesec, M. J. McNamara, D. I. Ives, J. W. Bodmann, D. J. Adelstein, Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials. Diseases of The Esophagus. ,vol. 28, pp. 547- 551 ,(2015) , 10.1111/DOTE.12241
James A. Miller, Daniel J. Ford, Mohamed S. Ahmed, Thom R. Loree, Two Cases of Pneumatosis Intestinalis during Cetuximab Therapy for Advanced Head and Neck Cancer Case reports in oncological medicine. ,vol. 2015, pp. 214236- 214236 ,(2015) , 10.1155/2015/214236
Xiaotian Zhang, Yuanhang Wu, Jifang Gong, Zhihao Lu, Jun Zhou, Xicheng Wang, Ming Lu, Jian Li, Yanshuo Cao, Yan Li, L Shen, None, [Trastuzumab combined with chemotherapy in patients with HER2-positive chemo-refractory advanced gastric or gastro-esophageal junction adenocarcinoma]. Chinese journal of oncology. ,vol. 36, pp. 223- 227 ,(2014) , 10.3760/CMA.J.ISSN.0253-3766.2014.03.014
Jing Tian, Ming Shang, Sheng-Bin Shi, Yong Han, Jun Xu, Cetuximab plus pemetrexed as second-line therapy for fluorouracil-based pre-treated metastatic esophageal squamous cell carcinoma. Cancer Chemotherapy and Pharmacology. ,vol. 76, pp. 829- 834 ,(2015) , 10.1007/S00280-015-2854-0